CLINICAL TRIAL: TRIAL OF ETHYL-EPA IN SUBJECTS WITH MILD TO MODERATE HUNTINGTON'

临床试验：在轻度至中度亨廷顿病受试者中进行乙基-EPA 试验

• 批准号: 7724936
• 负责人: JODY COREY-BLOOM
• 金额: $ 0.05万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-12-01 至 2008-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7724936
• 关键词: Acids; Chorea; Clinical; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Fatty Acids; Funding; Grant; Huntington Disease; Institution; Motor; Placebo Effect; Rate; Research; Research Personnel; Resources; Score; Source; United States National Institutes of Health; impression

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Compare with placebo the effect of ethyl-eicospaentaenoic acid an omega-3 fatty acid, on the Total Motor Score component (TMS) of the Unified Huntington's Disease Rating scale over a 6 month period of observation. Compare with placebo the effect of ethyl-EPA over a 6 month period of observation on chorea, the TMS and the clinical global impression score.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 在6个月的观察期内，将乙基二十碳五烯酸（一种ω-3脂肪酸）对统一亨廷顿氏病评定量表的总运动评分组分（TMS）的影响与安慰剂进行比较。 与安慰剂相比，在6个月的观察期内，乙基-EPA对舞蹈病、TMS和临床总体印象评分的影响。